Skip to main content
SCI logo

SCI — Investor Relations & Filings

Ticker · 4119 ISIN · TW0004119003 TW Manufacturing
Open in API
Filings indexed 1,697 across all filing types
Latest filing 2020-12-18 Investor Presentation
Country TW Taiwan
Listing TW 4119

About SCI

www.sci-pharmtech.com.tw

SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.

Recent filings

Filing Released Lang Actions
109年12月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a company's investor presentation meeting, including date, time, location, and links to presentation materials. The content focuses on a '法人說明會' which translates to 'investor presentation' or 'institutional investor briefing'. There is no financial data or report attached, just references to presentation files and meeting details. The document length is short (695 characters), and it is clearly a schedule or summary of investor presentations rather than a full report or announcement of voting results, management changes, or other filings. Therefore, the best classification is Investor Presentation (IP).
2020-12-18 Chinese
公告本公司受永豐金證券邀請參加法人說明會
Regulatory Filings Classification · 95% confidence The document is a short announcement about the company (4119 旭富) participating in an investor presentation (法人說明會) organized by a securities firm. It includes details such as date, time, location, and a brief summary of the event (explaining the company's operational overview). The document does not contain actual financial statements or detailed financial analysis, but rather serves as a notice of the event. The length is only 617 characters, indicating it is a brief announcement rather than a full report. According to the classification rules, such documents are best classified as Investor Presentation (IP) if they contain the presentation itself, or as Regulatory Filings (RNS) if they are just announcements. Since this document only announces the event and refers readers to another source for full financial information, it fits best under Regulatory Filings (RNS).
2020-12-17 Chinese
109年11月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and stock ownership information of company insiders, including directors, managers, and their related parties. It includes data on shares held, increases, decreases, and trust shares. The content is focused on insider shareholdings and transactions rather than financial results, management changes, or meeting materials. There is no indication of a full financial report, earnings release, or meeting announcement. The document is a regulatory disclosure of insider shareholdings, which fits the definition of Director's Dealing (DIRS) filings, which report personal share transactions by company directors and executives. The document length is sufficient and contains substantive data on insider holdings and changes. Therefore, the best classification is DIRS.
2020-12-14 Chinese
109年11月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders and related parties, including directors, managers, and major shareholders, with specific numbers of shares held, pledged shares, and related notes. It does not contain financial statements, earnings data, or management discussion. It is a disclosure of insider shareholdings and their changes, which aligns with the definition of Director's Dealing filings, reporting personal share transactions or holdings by company directors and executives. The document length is about 3150 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report. Therefore, the most appropriate classification is Director's Dealing (DIRS).
2020-12-14 Chinese
109年11月背書保證與資金貸與
Capital/Financing Update Classification · 90% confidence The document is a brief financial disclosure from a listed company (旭富) providing information about fund lending balances and endorsement guarantees for the current and previous months, with amounts all reported as zero. The content is concise, factual, and relates to capital or financing status but does not contain detailed financial statements or analysis. It is not a full report but an update on financing-related data. Given the nature of the data (fund lending and guarantees) and the brevity, this fits best under Capital/Financing Update (CAP).
2020-12-09 Chinese
109年11月營業收入
Financial Supplement Data Classification · 85% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 旭富, with data for November of the 109th year of the Republic of China calendar (which corresponds to 2020). It includes percentage changes compared to the previous year and explanatory notes about accounting standards (IFRS) and reporting practices. The document is very short (773 characters) and contains no detailed financial statements, management discussion, or audit information. It is essentially a brief financial data summary, likely a regulatory or public disclosure of monthly revenue figures. This fits best with a Financial Supplement Data (XLSX) or Fund Information / Factsheet (FS) category. However, since it is a brief summary of key financial figures and not a full factsheet or fund info, and given the nature of the data, the best fit is Financial Supplement Data (XLSX) as it provides supplementary financial data in a concise format. Confidence is high due to the clear financial data summary and short length.
2020-12-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.